Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

NYSE:IMAX - New York Stock Exchange, Inc. - CA45245E1097 - Common Stock - Currency: USD

23.5  +1.16 (+5.19%)

After market: 23.5 0 (0%)

Fundamental Rating

5

IMAX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. IMAX has an average financial health and profitability rating. IMAX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
IMAX had a positive operating cash flow in the past year.
In multiple years IMAX reported negative net income over the last 5 years.
IMAX had a positive operating cash flow in 4 of the past 5 years.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

IMAX has a Return On Assets of 3.14%. This is in the better half of the industry: IMAX outperforms 79.17% of its industry peers.
Looking at the Return On Equity, with a value of 8.70%, IMAX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.34%, IMAX is doing good in the industry, outperforming 76.39% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 21.76%.
The 3 year average ROIC (4.23%) for IMAX is below the current ROIC(5.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.14%
ROE 8.7%
ROIC 5.34%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 7.40%, IMAX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
IMAX's Profit Margin has declined in the last couple of years.
IMAX has a better Operating Margin (13.58%) than 83.33% of its industry peers.
IMAX's Operating Margin has declined in the last couple of years.
The Gross Margin of IMAX (54.00%) is better than 62.50% of its industry peers.
In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 13.58%
PM (TTM) 7.4%
GM 54%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMAX is destroying value.
IMAX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IMAX has less shares outstanding
The debt/assets ratio for IMAX is higher compared to a year ago.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 1.74. This is a bad value and indicates that IMAX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, IMAX is in the better half of the industry, outperforming 68.06% of the companies in the same industry.
IMAX has a debt to FCF ratio of 4.93. This is a neutral value as IMAX would need 4.93 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.93, IMAX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
IMAX has a Debt/Equity ratio of 0.89. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
IMAX has a Debt to Equity ratio (0.89) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 4.93
Altman-Z 1.74
ROIC/WACC0.81
WACC6.63%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.00 indicates that IMAX should not have too much problems paying its short term obligations.
With a decent Current ratio value of 2.00, IMAX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
IMAX has a Quick Ratio of 1.73. This is a normal value and indicates that IMAX is financially healthy and should not expect problems in meeting its short term obligations.
IMAX's Quick ratio of 1.73 is fine compared to the rest of the industry. IMAX outperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.73
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

IMAX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.06%.
IMAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.17% yearly.
The Revenue has decreased by -6.03% in the past year.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)1.06%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%58.82%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%7.74%

3.2 Future

The Earnings Per Share is expected to grow by 27.68% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.81% on average over the next years.
EPS Next Y35.06%
EPS Next 2Y23.63%
EPS Next 3Y19.34%
EPS Next 5Y27.68%
Revenue Next Year12.23%
Revenue Next 2Y8.51%
Revenue Next 3Y6.81%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.74, IMAX is valued on the expensive side.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than 77.78% of the companies in the same industry.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.33, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 18.32, IMAX is valued on the expensive side.
IMAX's Price/Forward Earnings ratio is rather cheap when compared to the industry. IMAX is cheaper than 86.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.37. IMAX is around the same levels.
Industry RankSector Rank
PE 24.74
Fwd PE 18.32
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 73.61% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 73.61% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.09
EV/EBITDA 12.71
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as IMAX's earnings are expected to grow with 19.34% in the coming years.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y23.63%
EPS Next 3Y19.34%

0

5. Dividend

5.1 Amount

IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (4/22/2025, 8:12:32 PM)

After market: 23.5 0 (0%)

23.5

+1.16 (+5.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners90.81%
Inst Owner Change0.09%
Ins Owners19.43%
Ins Owner Change1.65%
Market Cap1.25B
Analysts80
Price Target31.21 (32.81%)
Short Float %11.41%
Short Ratio6.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.85%
Min EPS beat(2)-6.42%
Max EPS beat(2)52.13%
EPS beat(4)3
Avg EPS beat(4)59.09%
Min EPS beat(4)-6.42%
Max EPS beat(4)138.86%
EPS beat(8)7
Avg EPS beat(8)75.55%
EPS beat(12)7
Avg EPS beat(12)6.13%
EPS beat(16)11
Avg EPS beat(16)18.4%
Revenue beat(2)0
Avg Revenue beat(2)-7.85%
Min Revenue beat(2)-11.37%
Max Revenue beat(2)-4.32%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)14.74%
Revenue beat(8)4
Avg Revenue beat(8)1.98%
Revenue beat(12)5
Avg Revenue beat(12)1.09%
Revenue beat(16)7
Avg Revenue beat(16)2.95%
PT rev (1m)2%
PT rev (3m)12.2%
EPS NQ rev (1m)-3.38%
EPS NQ rev (3m)-18.35%
EPS NY rev (1m)3.47%
EPS NY rev (3m)-1.86%
Revenue NQ rev (1m)1.4%
Revenue NQ rev (3m)-1.85%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)-2.42%
Valuation
Industry RankSector Rank
PE 24.74
Fwd PE 18.32
P/S 3.54
P/FCF 23.09
P/OCF 17.59
P/B 4.16
P/tB 6.14
EV/EBITDA 12.71
EPS(TTM)0.95
EY4.04%
EPS(NY)1.28
Fwd EY5.46%
FCF(TTM)1.02
FCFY4.33%
OCF(TTM)1.34
OCFY5.69%
SpS6.64
BVpS5.65
TBVpS3.83
PEG (NY)0.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 8.7%
ROCE 6.74%
ROIC 5.34%
ROICexc 6.22%
ROICexgc 9.28%
OM 13.58%
PM (TTM) 7.4%
GM 54%
FCFM 15.32%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexcg growth 3Y113.18%
ROICexcg growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 4.93
Debt/EBITDA 2.4
Cap/Depr 26.68%
Cap/Sales 4.79%
Interest Coverage 8.36
Cash Conversion 63.76%
Profit Quality 207.08%
Current Ratio 2
Quick Ratio 1.73
Altman-Z 1.74
F-Score6
WACC6.63%
ROIC/WACC0.81
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.06%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%58.82%
EPS Next Y35.06%
EPS Next 2Y23.63%
EPS Next 3Y19.34%
EPS Next 5Y27.68%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%7.74%
Revenue Next Year12.23%
Revenue Next 2Y8.51%
Revenue Next 3Y6.81%
Revenue Next 5YN/A
EBIT growth 1Y-12.14%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year216.7%
EBIT Next 3Y44.41%
EBIT Next 5Y37.72%
FCF growth 1Y23.26%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y20.85%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%